Browse Category

Financial Forecasts 17 December 2025

Cipher Mining (CIFR) Stock Today: News, Forecasts, and Analyst Outlook for December 17, 2025

Cipher Mining (CIFR) Stock Today: News, Forecasts, and Analyst Outlook for December 17, 2025

December 17, 2025 — Cipher Mining Inc. is back in focus as traders balance two competing narratives: near-term volatility tied to Bitcoin and broader “risk-on/risk-off” sentiment, versus a rapidly expanding pipeline of AI/HPC data-center contracts that management and many analysts believe could reshape the company’s revenue profile over the next several years.
Symbotic (SYM) Stock News Today (Dec. 17, 2025): Offering Fallout, Q4 Results, Analyst Forecasts, and What Investors Are Watching

Symbotic (SYM) Stock News Today (Dec. 17, 2025): Offering Fallout, Q4 Results, Analyst Forecasts, and What Investors Are Watching

Symbotic Inc. stock is under renewed pressure on Wednesday, Dec. 17, 2025, trading around $57 after a sharp pullback from earlier levels this week—an extension of the volatility that has defined SYM since late November’s earnings-driven surge. As of the latest available quote on Dec. 17, shares were down about 9% on the day, after opening near $62.69 and touching an intraday low in the mid-$50s.
17 December 2025
Warner Bros. Discovery (WBD) Series A Stock Today: Board Rejects Paramount’s $30 Bid, Backs Netflix Deal — News, Forecasts, and What Investors Are Watching (Dec. 17, 2025)

Warner Bros. Discovery (WBD) Series A Stock Today: Board Rejects Paramount’s $30 Bid, Backs Netflix Deal — News, Forecasts, and What Investors Are Watching (Dec. 17, 2025)

Warner Bros. Discovery, Inc. Series A Common Stock is trading in the middle of one of the most dramatic M&A battles the media industry has seen in years, after the company’s board formally urged shareholders not to tender into Paramount Skydance’s hostile offer and to instead support Warner Bros. Discovery’s already-signed combination with Netflix. Nasdaq+1
ZoomInfo Technologies (GTM) Stock Jumps After BTIG’s Buy Call: Today’s News, Analyst Forecasts, and What to Watch Next (Dec. 17, 2025)

ZoomInfo Technologies (GTM) Stock Jumps After BTIG’s Buy Call: Today’s News, Analyst Forecasts, and What to Watch Next (Dec. 17, 2025)

ZoomInfo Technologies Inc. stock pushed higher on Wednesday, December 17, 2025, as fresh Wall Street coverage and renewed focus on the company’s AI-led product roadmap added fuel to a month of choppy trading in small- and mid-cap software names. Shares were trading around the $10.5 level midday, extending a strong session that also saw GTM move through an intraday range roughly between $10.01 and $10.57. Investing.com+1
Pfizer Stock (PFE) Today: 2026 Guidance Triggers Fresh Scrutiny—News, Forecasts, Analyst Targets and Dividend Outlook (Dec. 17, 2025)

Pfizer Stock (PFE) Today: 2026 Guidance Triggers Fresh Scrutiny—News, Forecasts, Analyst Targets and Dividend Outlook (Dec. 17, 2025)

Pfizer Inc. stock is back in the spotlight on Wednesday, December 17, 2025, as investors digest the drugmaker’s newly issued 2026 outlook, a revised 2025 revenue view, and a longer runway to sustained growth than some shareholders had hoped for. Shares were trading around the mid-$25 range today, following a sharp reaction to the guidance update earlier this week.
Rezolve AI PLC (NASDAQ: RZLV) Stock News Today: $200M+ ARR Update Sparks Rally — Forecasts, Analyst Targets, and Key Risks (Dec. 17, 2025)

Rezolve AI PLC (NASDAQ: RZLV) Stock News Today: $200M+ ARR Update Sparks Rally — Forecasts, Analyst Targets, and Key Risks (Dec. 17, 2025)

December 17, 2025 — Rezolve AI PLC stock is in the spotlight after a company update indicated a sharp step-up in expected year-end momentum: December revenue is projected to exceed $17 million, while the company now expects to exit 2025 with annual recurring revenue above $200 million—alongside a milestone the market tends to reward: positive adjusted EBITDA. GlobeNewswire+1
Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts

Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts

Pfizer Inc. stock is back in the spotlight on December 17 as investors digest the company’s newly issued full-year 2026 financial guidance, along with a stack of fresh reporting and analyst commentary about what comes next for one of the world’s biggest drugmakers. The immediate market reaction has been skeptical: Pfizer’s outlook points to another year of flat-to-down top-line performance as COVID-era revenue continues to normalize and a looming loss-of-exclusivity cycle begins to bite harder. Pfizer+1
Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands, Inc. stock is back in the spotlight on December 17, 2025, as cannabis stocks react—again—to fast-moving headlines around potential U.S. federal marijuana rescheduling. In the latest session, TLRY traded around $13.94, up roughly 27% on the day, after swinging between about $10.32 and $14.54—a reminder that Tilray remains one of the market’s most headline-sensitive, momentum-driven names.
1 14 15 16 17 18 42